Targeted quantitative mass spectrometric immunoassay for human protein variants.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsMass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesDelineation of concentration ranges and longitudinal changes of human plasma protein variants.Mass spectrometry-based protein assays for in vitro diagnostic testing.Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoformsMass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality IndicatorsThe association of plasma cystatin C proteoforms with diabetic chronic kidney diseaseRapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumMass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.Human proteoforms as new targets for clinical mass spectrometry protein tests.Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes.
P2860
Q26738703-5F721AFE-EE7C-4010-9CD2-68EEDF520692Q26774903-2636B8CA-9133-4F29-895E-B9CA46745695Q33643266-E59CCDD5-DA41-4C8D-A9DE-049249D6607CQ33793513-12527A15-42B2-4974-9851-143AC1E041FBQ34216869-052A4C8C-51EE-4F64-B224-DE92A4C79CFDQ35166976-2E917844-AC26-487C-A228-C308476F3F6EQ35264312-75922A53-AB3C-4D5B-B053-EDB9B4ED109DQ36072219-E5A2CDC3-D628-490D-9A8E-353E59E791C9Q36072250-11B6388B-56FA-43A0-B981-EB8DFF4E3528Q36361741-3573D91F-F3EC-416A-9CE8-3D4B51EC280FQ36728166-A5F36D12-BA3D-4121-AA7D-5FB2149FFDB9Q37187946-469E789B-EA2C-4F73-9545-EB51708FE9BDQ37566426-25B9A71B-AE17-460D-BBB3-C3061919BB95Q38571078-EA50C6A7-B5BA-4F33-B489-3C7795067BB9Q38649742-F0FD6ED9-4717-41CF-93B1-258A341565B9Q47163663-6CCDC896-3D3C-49DD-9E10-A244ADBF2AFB
P2860
Targeted quantitative mass spectrometric immunoassay for human protein variants.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@ast
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@en
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@nl
type
label
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@ast
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@en
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@nl
prefLabel
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@ast
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@en
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@nl
P2860
P356
P1433
P1476
Targeted quantitative mass spectrometric immunoassay for human protein variants.
@en
P2093
Dobrin Nedelkov
Olgica Trenchevska
P2860
P2888
P356
10.1186/1477-5956-9-19
P577
2011-04-08T00:00:00Z
P5875
P6179
1045770775